Cargando…

How to Improve the Cardiac Function and Clinical Outcomes in Patients with Heart Failure with a Mid-range Ejection Fraction

Detalles Bibliográficos
Autor principal:	Imamura, Teruhiko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Japanese Society of Internal Medicine 2021
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8313916/ https://www.ncbi.nlm.nih.gov/pubmed/33551415 http://dx.doi.org/10.2169/internalmedicine.6954-20

Ejemplares similares

Heart rate in heart failure with mid-range ejection fraction
por: Yılmaz, Mehmet Birhan
Publicado: (2019)

Spironolactone use is associated with improved outcomes in heart failure with mid‐range ejection fraction
por: Enzan, Nobuyuki, et al.
Publicado: (2020)

Heart Failure with Mid-Range Ejection Fraction - State of the Art
por: Mesquita, Evandro Tinoco, et al.
Publicado: (2019)

Heart failure with mid-range or mildly reduced ejection fraction
por: Savarese, Gianluigi, et al.
Publicado: (2021)

Treatment of Heart Failure with Mid-Range Ejection Fraction: What Is the Evidence
por: Koufou, Eleni-Evangelia, et al.
Publicado: (2021)

Pulmonary Hypertension in Patients With Heart Failure With Mid-Range Ejection Fraction
por: Maeder, Micha T., et al.
Publicado: (2021)

Catheter Ablation for Atrial Fibrillation Targeting Incremental Left Ventricular Ejection Fraction
por: Chapman, Mimi, et al.
Publicado: (2021)

Epicardial Adipose Tissue and Outcome in Heart Failure With Mid-Range and Preserved Ejection Fraction
por: van Woerden, Gijs, et al.
Publicado: (2021)

Predictors of cardiac function in acute heart failure patients with mid‐range ejection fraction: AURORA study
por: Yanagawa, Kyosuke, et al.
Publicado: (2019)

The impact of heart rate on patients diagnosed with heart failure with mid-range ejection fraction
por: Xin, Yanguo, et al.
Publicado: (2019)

Epicardial fat in heart failure patients with mid‐range and preserved ejection fraction
por: van Woerden, Gijs, et al.
Publicado: (2018)

Heart Failure With Mid-range or Recovered Ejection Fraction: Differential Determinants of Transition
por: Margonato, Davide, et al.
Publicado: (2020)

Impact of diastolic dysfunction on outcome in heart failure patients with mid‐range or reduced ejection fraction
por: Liu, Dan, et al.
Publicado: (2021)

Heart failure with preserved ejection fraction: A distinct heart failure phenotype?
por: Triposkiadis, Filippos, et al.
Publicado: (2022)

Heart failure with mid‐range ejection fraction: characterization of patients from the PINNACLE Registry®
por: Ibrahim, Nasrien E., et al.
Publicado: (2019)

Central and Obstructive Apneas in Heart Failure With Reduced, Mid-Range and Preserved Ejection Fraction
por: Borrelli, Chiara, et al.
Publicado: (2019)

Rehospitalization burden and morbidity risk in patients with heart failure with mid‐range ejection fraction
por: Santas, Enrique, et al.
Publicado: (2020)

Heart Failure With Mid-range Ejection Fraction: Every Coin Has Two Sides
por: Zhu, Kaiyuan, et al.
Publicado: (2021)

Treatment of Heart Failure With Mid-Range Ejection Fraction: A Summary of Current Evidence
por: Ma, Teng, et al.
Publicado: (2021)

Changes in the Left Ventricular Ejection Fraction and Outcomes in Hospitalized Heart Failure Patients with Mid-range Ejection Fraction: A Prospective Observational Study
por: Tsukamoto, Kei, et al.
Publicado: (2020)

Initial Experience of Vericiguat Treatment in Patients with Heart Failure and Reduced Ejection Fraction
por: Nakamura, Makiko, et al.
Publicado: (2023)

Efficacy and safety of spironolactone in the heart failure with mid-range ejection fraction and heart failure with preserved ejection fraction: A meta-analysis of randomized clinical trials
por: Xiang, Yajie, et al.
Publicado: (2019)

Hypoalbuminemia in Patients with Acute Decompensated Heart Failure
por: Imamura, Teruhiko
Publicado: (2019)

Prognostic value of high-sensitivity cardiac troponin I in heart failure patients with mid-range and reduced ejection fraction
por: Lokaj, Petr, et al.
Publicado: (2021)

β-blocker and 1-year outcomes among patients hospitalized for heart failure with mid-range ejection fraction
por: Wang, Bin, et al.
Publicado: (2021)

Assessment of right ventricular systolic function in heart failure with preserved, reduced and mid-range ejection fraction
por: Mostafa, Shaimaa
Publicado: (2019)

Left atrial function and maximal exercise capacity in heart failure with preserved and mid‐range ejection fraction
por: Maffeis, Caterina, et al.
Publicado: (2020)

Heart Failure With Preserved, Mid-Range, and Reduced Ejection Fraction: The Misleading Definition of the New Guidelines
por: Fedele, Francesco, et al.
Publicado: (2017)

Silent Cerebral Infarctions with Reduced, Mid-Range and Preserved Ejection Fraction in Patients with Heart Failure
por: Oliveira, Márcia Maria Carneiro, et al.
Publicado: (2018)

The prognosis of mid‐range ejection fraction heart failure: a systematic review and meta‐analysis
por: Altaie, Saif, et al.
Publicado: (2018)

Particularities of Older Patients with Obstructive Sleep Apnea and Heart Failure with Mid-Range Ejection Fraction
por: Ardelean, Carmen Loredana, et al.
Publicado: (2019)

Impact of atrial fibrillation in patients with heart failure and reduced, mid-range or preserved ejection fraction
por: Son, Mi Kyoung, et al.
Publicado: (2020)

Heart Failure With Mid-range Ejection Fraction: A Distinctive Subtype or a Transitional Stage?
por: Zhou, Qing, et al.
Publicado: (2021)

Prognostic value of reverse remodelling criteria in heart failure with reduced or mid‐range ejection fraction
por: Aimo, Alberto, et al.
Publicado: (2021)

Atrial fibrillation ablation in heart failure with mid-range ejection fraction: Is it time to open the champagne?
por: Nagarakanti, Rangadham, et al.
Publicado: (2023)

Association between left atrial sphericity index and clinical outcomes in patients with systolic heart failure
por: Chapman, Mimi, et al.
Publicado: (2021)

How to Demonstrate the Impact of Cardiac Rehabilitation on Cardio-renal Protection
por: Imamura, Teruhiko
Publicado: (2019)

Implication of Mineralocorticoid Receptor Antagonist Esaxerenone in Patients With Heart Failure With Preserved Ejection Fraction
por: Imamura, Teruhiko, et al.
Publicado: (2021)

Use of angiotensin receptor blocker is associated with improved 1 year mortality in heart failure with mid‐range ejection fraction
por: Wang, Bin, et al.
Publicado: (2021)

Vericiguat: a fifth cornerstone in the treatment of heart failure with reduced ejection fraction?
por: Hammer, Andreas, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_c720eg65rfnlve0gb7pedu5ati